Defining the Substrate Specificity Determinants Recognized by the Active Site of C-Terminal Src Kinase-Homologous Kinase (CHK) and Identification of β-Synuclein as a Potential CHK Physiological Substrate

被引:9
作者
Ia, Kim K. [1 ,2 ]
Jeschke, Grace R. [5 ]
Deng, Yang [5 ]
Kamaruddin, Mohd Aizuddin [1 ,2 ]
Williamson, Nicholas A. [2 ]
Scanlon, Denis B. [2 ]
Culvenor, Janetta G. [3 ]
Hossain, Mohammed Iqbal [1 ,2 ]
Purcell, Anthony W. [1 ,2 ]
Liu, Sheng [4 ]
Zhu, Hong-Jian [4 ]
Catimel, Bruno [6 ]
Turk, Benjamin E. [5 ]
Cheng, Heung-Chin [1 ,2 ]
机构
[1] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia
[2] Univ Melbourne, Biotechnol & Mol Sci Inst Bio21, Parkville, Vic 3010, Australia
[3] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia
[4] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3010, Australia
[5] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[6] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Parkville, Vic 3010, Australia
基金
澳大利亚国家健康与医学研究理事会; 美国国家卫生研究院;
关键词
ALPHA-SYNUCLEIN; FAMILY KINASES; CSK; PHOSPHORYLATION; MECHANISMS; EXPRESSION; KESTREL;
D O I
10.1021/bi2001938
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
C-Terminal Src kinase-homologous kinase (CHK) exerts its tumor suppressor function by phosphorylating the C-terminal regulatory tyrosine of the Src-family kinases (SFKs). The phosphorylation suppresses their activity and oncogenic action. In addition to phosphorylating SFKs, CHK also performs non-SFK-related functions by phosphorylating other cellular protein substrates. To define these non-SFK-related functions of CHK, we used the "kinase substrate tracking and elucidation" method to search for its potential physiological substrates in rat brain cytosol. Our search revealed beta-synuclein as a potential CHK substrate, and Y127 in beta-synuclein as the preferential phosphorylation site. Using peptides derived from beta-synuclein and positional scanning combinatorial peptide library screening we defined the optimal substrate phosphorylation sequence recognized by the CHK active site to be E-x-[Phi/E/D]-Y-Phi-x-Phi, where Phi) and x represent hydrophobic residues and any residue, respectively. Besides beta-synudein, cellular proteins containing motifs resembling this sequence are potential CHK substrates. Intriguingly, the CHK-optimal substrate phosphorylation sequence bears little resemblance to the C-terminal tail, sequence of SFKs, indicating that interactions between the CHK( active site and the local determinants near the C-terminal regulatory tyrosine of SFKs play only a minor role in governing specific phosphorylation of SFKs by CHK Our results imply that recognition of SFK, by CHK is mainly governed by interactions between motifs located distally from the active Site of CHK and determinants spatially separate from the C-terminal regulatory tyrosine in SFKs. Thus, besides assisting in the identification of potential CHK physiological substrates, our findings Shed new light on how CHK recognizes SFKs and other protein substrates.,
引用
收藏
页码:6667 / 6677
页数:11
相关论文
共 34 条
[1]   Development of the procedures for high-yield expression and rapid purification of active recombinant Csk-homologous kinase (CHK): Comparison of the catalytic activities of CHK and CSK [J].
Chan, Khai-Chew ;
Lio, Daisy Sio-Seng ;
Dobson, Renwick C. J. ;
Jarasrassamee, Boonyarin ;
Hossain, Mohammed I. ;
Roslee, Aainaa K. ;
Ia, Kim K. ;
Perugini, Matthew A. ;
Cheng, Heung-Chin .
PROTEIN EXPRESSION AND PURIFICATION, 2010, 74 (02) :139-147
[2]  
CHENG HC, 2006, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A000705.01
[3]   C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)-endogenous negative regulators of Src-family protein kinases [J].
Chong, YP ;
Mulhern, TD ;
Cheng, HC .
GROWTH FACTORS, 2005, 23 (03) :233-244
[4]   A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity [J].
Chong, YP ;
Mulhern, TD ;
Zhu, HJ ;
Fujita, DJ ;
Bjorge, JD ;
Tantiongco, JP ;
Sotirellis, N ;
Lio, DSS ;
Scholz, G ;
Cheng, HC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (20) :20752-20766
[5]   Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases [J].
Chong, YP ;
Ia, KK ;
Mulhern, TD ;
Cheng, HC .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2) :210-220
[6]   C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases [J].
Chong, Yuh-Ping ;
Chan, Andrew S. ;
Chan, Khai-Chew ;
Williamson, Nicholas A. ;
Lerner, Edwina C. ;
Smithgall, Thomas E. ;
Bjorge, Jeffrey D. ;
Fujita, Donald J. ;
Purcell, Anthony W. ;
Scholz, Glen ;
Mulhern, Terrence D. ;
Cheng, Heung-Chin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) :32988-32999
[7]   KESTREL: a powerful method for identifying the physiological substrates of protein kinases [J].
Cohen, P ;
Knebel, A .
BIOCHEMICAL JOURNAL, 2006, 393 :1-6
[8]   Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited -: NAC and α-synuclein are not associated with Aβ amyloid [J].
Culvenor, JG ;
McLean, CA ;
Cutt, S ;
Campbell, BCV ;
Maher, F ;
Jäkälä, P ;
Hartmann, T ;
Beyreuther, K ;
Masters, CL ;
Li, QX .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1173-1181
[9]   Structural recognition of an optimized substrate for the ephrin family of receptor tyrosine kinases [J].
Davis, Tara L. ;
Walker, John R. ;
Allali-Hassani, Abdellah ;
Parker, Sirlester A. ;
Turk, Benjamin E. ;
Dhe-Paganon, Sirano .
FEBS JOURNAL, 2009, 276 (16) :4395-4404
[10]   A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain [J].
Fujita, Masayo ;
Sugama, Shuei ;
Sekiyama, Kazunari ;
Sekigawa, Akio ;
Tsukui, Tohru ;
Nakai, Masaaki ;
Waragai, Masaaki ;
Takenouchi, Takato ;
Takamatsu, Yoshiki ;
Wei, Jianshe ;
Rockenstein, Edward ;
LaSpada, Albert R. ;
Masliah, Eliezer ;
Inoue, Satoshi ;
Hashimoto, Makoto .
NATURE COMMUNICATIONS, 2010, 1